IL1B and Alzheimer disease: A tauopathy mouse model in one study showed that the earliest stages of the characteristic neurodegeneration in Alzheimer’s disease included activation of microglial cells, elevated proinflammatory cytokine levels such as IL-1β, and neuronal damage [15].